Dr. Ronit Shaltiel-Karyo
Dr. Ronit Shaltiel-Karyo, Ph.D, MBA
Director of R&D and
Innovation
Dr. Ronit Shaltiel Karyo is a scientific leader with a Ph.D in Biotechnology and an MBA. Starting from her academic years, Dr. Ronit gained years of experience in researching CNS related indications, with the focus on Alzheimer’s and Parkinson’s diseases. Following her graduation, Dr. Ronit worked for many years as a director of R&D at Neuroderm, a pharma company which develop drug-device combination products for Parkinson’s patients. The company was acquired in 2017 for $1.1 billion by the Giant Japanese company, Mitsubishi Tanabe.
Dr. Ronit brings great experience in both the pharma industry and the cosmetic/OTC/wellness industry, with broad international experience in biotechnological, pharmaceutical, device, and cannabis companies.
Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract
Ronit Shaltiel-Karyo a, Dan Davidi a, Moran Frenkel-Pinter a, Michael Ovadia a, Daniel Segal a b, Ehud Gazit a
Biochimica et Biophysica Acta (BBA) - General SubjectsVolume 1820, Issue 10,October 2012, Pages 1628-1635
Structural Basis for Inhibiting β-Amyloid Oligomerization by a Non-coded β-Breaker-Substituted Endomorphin Analogue
Anat Frydman-Marom, Marino Convertino, Riccardo Pellarin, Ayala Lampel, Ronit Shaltiel-Karyo, Daniel Segal, Amedeo Caflisch, Deborah E. Shalev, and Ehud Gazit
A Novel, Sensitive Assay for Behavioral Defects in Parkinson's Disease Model Drosophila
Ronit Shaltiel-Karyo,Dan Davidi,Yotam Menuchin,Moran Frenkel-Pinter,Mira Marcus-Kalish,2John Ringo,Ehud Gazit,1and Daniel Segal Animal Models of Parkinson's Disease 2012
Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies
Ronit Shaltiel-Karyo,Moran Frenkel-Pinter,Nirit Egoz-Matia,Anat Frydman-Marom,Deborah E. Shalev,Daniel Segal,Ehud Gazit
A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent α-Synuclein (α-syn) Aggregation Inhibitor
Ronit Shaltiel-Karyo,Moran Frenkel-Pinter, Edward Rockenstein, Eliezer Masliah, Daniel Segal Ehud Gazit
Subscribe to our emails
Promotions, new products and sales. Directly to your inbox.